Evidence map›Paper›PMID 40755462›Full record

ReviewInternational journal of nanomedicine2025

Recent Advances in Membrane-Coated Micro/Nanomotors in Biological Applications.

Kaiting Zhao, Jia Xu, Wei Song, Jie Cheng, Abdullah Al Mamun, Yingfeng Tu, Jian Xiao, Shuanghu Wang, Ning Zhang

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaiting Zhao *Department of Emergency, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.
Jia Xu *Department of Pharmacy, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000 People's Republic of China.
Wei SongKey Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.
Jie ChengKey Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.
Abdullah Al MamunKey Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.ORCID 0000-0001-9936-3925
Yingfeng TuSchool of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, 510515, People's Republic of China.
Jian XiaoMolecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, People's Republic of China.ORCID 0000-0001-7374-6506
Shuanghu WangKey Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.ORCID 0000-0002-0057-267X
Ning ZhangDepartment of Emergency, The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integration of synthetic micro/nanomotors (MNMs) with natural biomaterials derived from cell membranes has emerged as a highly promising strategy for advancing biological applications. The membrane-coated MNM offers distinct advantages over earlier MNMs dependent on chemical fuels such as hydrogen peroxide, which were prone to poor biocompatibility and harmful byproducts. These include enhanced biocompatibility, immune evasion via natural membrane surfaces, multifunctionality for drug delivery, self-propulsion in complex environments, self-degradation to reduce residual toxicity and inherent imaging capabilities enabling real-time tracking. This review provides a comprehensive overview of the integration of various types of micromotors with natural cell membranes commonly present in the circulatory system. Additionally, it summarizes the methodologies for the preparation, characterization and functional evaluation of biofilm-modified micromotors. The present article also critically examines current developments in biofilm-modified micromotors, addressing their challenges and limitations in enhancing clinical efficacy and facilitating transition to clinical trials in humans.

Indexed as

Cell MembraneCoated Materials, BiocompatibleAnimalsBiocompatible MaterialsBiofilmsDrug Delivery SystemsHumansBiocompatible MaterialsCoated Materials, Biocompatibledrug deliverymembrane-coatedmicro/nanomotorsnanodrugsself-propulsion

Identifiers

PMID40755462
PMCPMC12315904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.